An Advanced Vacuum and Light Technology for the Treatment of
... inflammatory acne lesion. Successfully treating the micro-comedones and comedones with the Acleara, something that could not be done with previous devices, lessens the potential for an inflammatory and or cystic acne lesion to develop. The mechanism for treating these small comedones is postulated t ...
... inflammatory acne lesion. Successfully treating the micro-comedones and comedones with the Acleara, something that could not be done with previous devices, lessens the potential for an inflammatory and or cystic acne lesion to develop. The mechanism for treating these small comedones is postulated t ...
View / pdf version of BPJ 23
... ▪▪ 66% of returned items to a pharmacy were medications that had been dispensed for greater than a one month period.7 Treatment change and bereavement are the most commonly reported reasons for returning medications.4, 7–9 Other reasons include; medicines no longer needed or expired, adverse drug re ...
... ▪▪ 66% of returned items to a pharmacy were medications that had been dispensed for greater than a one month period.7 Treatment change and bereavement are the most commonly reported reasons for returning medications.4, 7–9 Other reasons include; medicines no longer needed or expired, adverse drug re ...
(Eds.), 2010. Treatment Resistant Anxiety Disorders
... (Rowa, Antony, Summerfeldt, Purdon, & Swinson, 2004). In interpreting these results it is important to underline that efficacy likely depends on the extent to which ERP to salient feared stimuli can be reproduced in the office and on the patient’s capacity to engage in ERP homework alone between ses ...
... (Rowa, Antony, Summerfeldt, Purdon, & Swinson, 2004). In interpreting these results it is important to underline that efficacy likely depends on the extent to which ERP to salient feared stimuli can be reproduced in the office and on the patient’s capacity to engage in ERP homework alone between ses ...
English - Jornal Brasileiro de Pneumologia
... Similarly, the clinical evolution, with or without improvement of the symptoms and objective parameters, is typically used as the standard method to measure the efficacy of the treatment instituted. Although there are no doubts that such aspects are very important and that they should never be negle ...
... Similarly, the clinical evolution, with or without improvement of the symptoms and objective parameters, is typically used as the standard method to measure the efficacy of the treatment instituted. Although there are no doubts that such aspects are very important and that they should never be negle ...
An analysis of factors contributing to poor outcomes in Cystic Fibrosis
... The diagnosis of cystic fibrosis is based on the clinical features, genetic screening for a CFTR gene mutation and an abnormal sweat test indicated by repeatedly elevated chloride levels.5 In addition, faecal elastase is measured to help identify patients with pancreatic insufficienc ...
... The diagnosis of cystic fibrosis is based on the clinical features, genetic screening for a CFTR gene mutation and an abnormal sweat test indicated by repeatedly elevated chloride levels.5 In addition, faecal elastase is measured to help identify patients with pancreatic insufficienc ...
25. HIV and Pulmonary Diseases
... of patients with a CD4+ T-cell count of > 200/µl with medication effective against S. pneumoniae, H. influenzae und S. aureus is indicated. However, there are no controlled studies available to support this. In accordance with recommended therapies for community acquired pneumonia with co-morbidity, ...
... of patients with a CD4+ T-cell count of > 200/µl with medication effective against S. pneumoniae, H. influenzae und S. aureus is indicated. However, there are no controlled studies available to support this. In accordance with recommended therapies for community acquired pneumonia with co-morbidity, ...
PAKISTAN PAEDIATRIC JOURNAL
... illustrations. Rarity itself of a disease condition is not an acceptable condition of case reports. The peer review process takes usually six weeks after the manuscript submission. Revisions are usually requested to take account of criticism and comments made by referees. Three copies of revised man ...
... illustrations. Rarity itself of a disease condition is not an acceptable condition of case reports. The peer review process takes usually six weeks after the manuscript submission. Revisions are usually requested to take account of criticism and comments made by referees. Three copies of revised man ...
author query form - Texas Tech University Health Sciences Center
... weakness, and lightheadedness. Ingestion of 5 to 10 times the normal dose can cause severe hypotension along with bradycardia, pulmonary edema, renal failure, and other signs of heart failure. The electrocardiogram (ECG) may show bradycardia, arrhythmia, and complete heart block.8,9 As in our case, ...
... weakness, and lightheadedness. Ingestion of 5 to 10 times the normal dose can cause severe hypotension along with bradycardia, pulmonary edema, renal failure, and other signs of heart failure. The electrocardiogram (ECG) may show bradycardia, arrhythmia, and complete heart block.8,9 As in our case, ...
Lichen Ruber Planus of the Mucous Membrane of Oral Cavity
... uneven outlines. Their surface was covered with fibrous coat, which was removed with the appearance of blood spots on the surface. Patients with erosive-ulcerous LRP frequently complained of pain and burning sensation, especially after taking alcohol drinks, hot, rough or spicy food. The biggest dif ...
... uneven outlines. Their surface was covered with fibrous coat, which was removed with the appearance of blood spots on the surface. Patients with erosive-ulcerous LRP frequently complained of pain and burning sensation, especially after taking alcohol drinks, hot, rough or spicy food. The biggest dif ...
Quintuple the daily maintenance dose of buprenorphine given every
... This study by Petry et al provides information for clinicians regarding the maximal interdose interval of BUP for the treatment of opioid addiction. The study showed the maximum interval to be < 5 days when 5 times the daily maintenance dose was given. A number of factors will influence the degree t ...
... This study by Petry et al provides information for clinicians regarding the maximal interdose interval of BUP for the treatment of opioid addiction. The study showed the maximum interval to be < 5 days when 5 times the daily maintenance dose was given. A number of factors will influence the degree t ...
Faculty of Medicine
... member. The students are also expected to be fully integrated with these firms, clerking patients and presenting them on scheduled rounds to the consultants in the firm. They are also expected to divide the patients of the firm they are attending with amongst themselves and each student is expected ...
... member. The students are also expected to be fully integrated with these firms, clerking patients and presenting them on scheduled rounds to the consultants in the firm. They are also expected to divide the patients of the firm they are attending with amongst themselves and each student is expected ...
Beth Israel Deaconess Medical Center Healthcare Associates HIV
... decades with the advent of combination antiretroviral therapy and the introduction of viral load testing and resistance testing in clinical practice. Patients are hospitalized less frequently with opportunistic infections and are living longer. However, with this encouraging news have come important ...
... decades with the advent of combination antiretroviral therapy and the introduction of viral load testing and resistance testing in clinical practice. Patients are hospitalized less frequently with opportunistic infections and are living longer. However, with this encouraging news have come important ...
apo-clomipramine
... Caution is indicated in patients with hyperthyroidism or patients receiving thyroid preparations, owing to the possibility of cardiac toxicity. In patients with liver disease, periodic monitoring of hepatic enzyme levels is recommended. Although changes in the white blood cell count have been report ...
... Caution is indicated in patients with hyperthyroidism or patients receiving thyroid preparations, owing to the possibility of cardiac toxicity. In patients with liver disease, periodic monitoring of hepatic enzyme levels is recommended. Although changes in the white blood cell count have been report ...
Diagnosis of Reversible Versus Irreversible Cerebral
... prompt, dramatic response with complete resolution of the symptoms (table 1). The weakness cleared in all these patients in less than ten minutes. The improvement lasted in three patients 30 minutes and in four was long-lasting without recurrence of the weakness. Four out of 20 patients had a partia ...
... prompt, dramatic response with complete resolution of the symptoms (table 1). The weakness cleared in all these patients in less than ten minutes. The improvement lasted in three patients 30 minutes and in four was long-lasting without recurrence of the weakness. Four out of 20 patients had a partia ...
AAOMS Position Paper on Medication
... Intravenous (IV) bisphosphonates (BPs) are antiresorptive medications used to manage cancer-related conditions including hypercalcemia of malignancy, skeletal-related events (SRE) associated with bone metastases in the context of solid tumors such as breast cancer, prostate cancer and lung cancers, ...
... Intravenous (IV) bisphosphonates (BPs) are antiresorptive medications used to manage cancer-related conditions including hypercalcemia of malignancy, skeletal-related events (SRE) associated with bone metastases in the context of solid tumors such as breast cancer, prostate cancer and lung cancers, ...
using what we have: combining medications to achieve remission
... significantly increase the risk of relapse and recurrence (Paykel 1995). In addition to increased risk of relapse and recurrence, there are several other possible consequences of failing to achieve remission, including continued psychosocial impairments, increased use of medical services, potentiall ...
... significantly increase the risk of relapse and recurrence (Paykel 1995). In addition to increased risk of relapse and recurrence, there are several other possible consequences of failing to achieve remission, including continued psychosocial impairments, increased use of medical services, potentiall ...
Efficacy of Orally Administration of Banxia Houpu Tang With Low
... some patients took foods orally by caregivers and two patients took food by percutaneous endoscopic gastric（PEG）tube. No patients took cholinesterase inhibitors, and some of the patients took antipsychotics and dopamine agonists. All 11 patients were administered BHT with ACEI orally or via PEG tube ...
... some patients took foods orally by caregivers and two patients took food by percutaneous endoscopic gastric（PEG）tube. No patients took cholinesterase inhibitors, and some of the patients took antipsychotics and dopamine agonists. All 11 patients were administered BHT with ACEI orally or via PEG tube ...
Immunologic Aspects of Hypoplastic Myelodysplastic Syndrome
... patients, cyclosporine was discontinued due to toxic side effects. Conversely, in a small British study (six patients), none of the patients responded to cyclosporine alone.49 Cyclosporine was added to methylprednisolone in a Japanese study of 18 patients with MDS43; only six patients received cyclo ...
... patients, cyclosporine was discontinued due to toxic side effects. Conversely, in a small British study (six patients), none of the patients responded to cyclosporine alone.49 Cyclosporine was added to methylprednisolone in a Japanese study of 18 patients with MDS43; only six patients received cyclo ...
awareness day - Neuropathy Action Foundation
... government entities, etc. take the time to spend the day with neuropathy patients to educate them on their services and products. They provide valuable information that may help you understand more about your treatments/medications, your insurance, your rights to appeal decisions made by your insura ...
... government entities, etc. take the time to spend the day with neuropathy patients to educate them on their services and products. They provide valuable information that may help you understand more about your treatments/medications, your insurance, your rights to appeal decisions made by your insura ...
Migraine Treatment: 2014-2015
... who are not at risk for coronary artery disease (CAD). Patients in their 50s or 60s can use these drugs, but they should be prescribed cautiously, and only in those patients who have been screened for CAD. Over the 23 years that triptans have been available, serious side effects have been few; they ...
... who are not at risk for coronary artery disease (CAD). Patients in their 50s or 60s can use these drugs, but they should be prescribed cautiously, and only in those patients who have been screened for CAD. Over the 23 years that triptans have been available, serious side effects have been few; they ...
VI nerve palsy Clinical Approach and Treatment in adult population
... abduction, the incomitances, forced duction test Aim: correction of esodeviation, improvement of abduction, increase of size of the diplopia free binocular field ...
... abduction, the incomitances, forced duction test Aim: correction of esodeviation, improvement of abduction, increase of size of the diplopia free binocular field ...
Personalised medicine in exacerbations of COPD: the beginnings EDITORIAL Sanjay Sethi
... exclusion criteria for the study, with prior recent antibiotic and corticosteroid use and need for intensive care being the most common (and appropriate) reasons for exclusion. Most patients received systemic corticosteroids. The primary outcome of treatment failure was measured at day 3, and was co ...
... exclusion criteria for the study, with prior recent antibiotic and corticosteroid use and need for intensive care being the most common (and appropriate) reasons for exclusion. Most patients received systemic corticosteroids. The primary outcome of treatment failure was measured at day 3, and was co ...
Secondary Hemophagocytic Lymphohistiocytosis in Adults: An
... unregulated inflammation. Corticosteroids may be used as monotherapy for secondary causes of HLH; however, the physician should expect to broaden treatment if the disorder does not respond or progresses. In highly suspicious cases, treatment may be initiated before obtaining final results of all dia ...
... unregulated inflammation. Corticosteroids may be used as monotherapy for secondary causes of HLH; however, the physician should expect to broaden treatment if the disorder does not respond or progresses. In highly suspicious cases, treatment may be initiated before obtaining final results of all dia ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.